Acute and Subacute Toxicity studies on Siddha Herbo-mineral Anti-arthritic formulation "Pooneeru Diravagam" in experimental animal models
Journal Title: International Journal of Clinical Pharmacology & Toxicology(IJCPT) - Year 2015, Vol 4, Issue 1
Abstract
Ethno pharmacological Relevance: 60% of the world's population depends on traditional medicine [1]. It is in use for primary health care and general health care among rural, urban, semi urban in both developed and developing countries parallel to the usage of western medicines. Pooneeru diravagam is an indigenous Siddha medicine [2]. There is a huge cry, tall fake claims regarding the safety and efficacy of Siddha formulations. The present study is aimed to evaluate the safety of Pooneeru diravagam by determining any toxicity changes through acute and sub-acute toxicity studies per oral administration in swiss albino rats. Materials and Methods: Acute toxicity study was carried out as per OECD Guideline-423 in healthy swiss albino female rat weighing 200–245 gm. The Study was carried out in three female rats under fasting condition; signs of toxicity were observed for every one hour for first 24 hours and every day for fortnight from the beginning of the study. Sub acute toxicity study was carried out as per OECD guidelines-407 in swiss albino rats of either sex weighing 220–245 gm of three groups of 6 rats each (Three male and three female) at two dosage levels 0.2 ml and 0.4 ml of 28 days continuous drug administration (oral route). Results: The animals were sacrificed on the 29th day and various blood biochemical parameters haematological and clinical signs were measured. The organ morphology such as kidney, liver, heart, lungs, spleen, pancreas, brain, ovaries and testes were processed for Histopathological study. The results of sub-acute toxicity on 29th day did not show any evidence of changes. Physiological, Hematological as well as Histopathological parameters remained unaltered when compared with control animals throughout the dosing period. Conclusions: From the results it is concluded that usage of pooneeru diravagam at the dosage of 0.4 ml/kg p.o is safe for the population suffering from rheumatoid arthritis.
Authors and Affiliations
Padhmavathi J
Keywords
Related Articles
- EP ID EP201706
- DOI 10.19070/2167-910X-1500025
- Views 67
- Downloads 0
The Prophylactic and Therapeutic Effects of Safranal and Selenite on Liver Damage Induced by Thyrotoxicosis in Adult Male Rats
Aim: To evaluate the prophylactic and therapeutic activities of safranal and selenite against liver damage induced by thyrotoxicosis. Materials and Methods: Thyrotoxicosis was induced by thyroxine (L-T4, 500 μg/kg, s.c.)...
Toxic Compounds Analysis by High Performance Liquid Chromatography
Toxic Compounds Analysis by High Performance Liquid Chromatography
Oxidative Stress in Paediatric Patients with Diabetes Mellitus Type 1 And Relationship with Glucemic Levels
This study was made in paediatric patients affected by diabetes mellitus type 1. Fasting blood samples were obtained to determine glucose, bilirrubin, uric acid, ascorbic acid, ceruloplasmin , albúmin and LDLox levels. W...
Effect of Some Anti hypertensive Drugs on Alkaline Phosphatase and DNA of Mice
The dislipidemias are a risk factor well recognized of the cardiovascular diseases and constitute a problem of public health. A descriptive study in 150 patient elders of 30 years with diagnosis of Izquemic Cardiopathyes...
PPAR α/γ Agonist in Management of Diabetic Dyslipidemia: A Review
Cardiovascular diseases are major contributors of mortality and morbidity in patients with type 2 diabetes mellitus (T2DM), while dyslipidemia and hyperglycemia are key modifiable risk factors to prevent coronary artery...